Capturing the variety of clinical pathways in patients with schizophrenic disorders through state sequences analysis.


Journal

BMC medical research methodology
ISSN: 1471-2288
Titre abrégé: BMC Med Res Methodol
Pays: England
ID NLM: 100968545

Informations de publication

Date de publication:
29 07 2023
Historique:
received: 28 10 2022
accepted: 20 07 2023
medline: 31 7 2023
pubmed: 30 7 2023
entrez: 29 7 2023
Statut: epublish

Résumé

Care pathways are increasingly being used to enhance the quality of care and optimize the use of resources for health care. Nevertheless, recommendations regarding the sequence of care are mostly based on consensus-based decisions as there is a lack of evidence on effective treatment sequences. In a real-world setting, classical statistical tools were insufficient to consider a phenomenon with such high variability adequately and have to be integrated with novel data mining techniques suitable for identifying patterns in complex data structures. Data-driven techniques can potentially support empirically identifying effective care sequences by extracting them from data collected routinely. The purpose of this study is to perform a state sequence analysis (SSA) to identify different patterns of treatment and to asses whether sequence analysis may be a useful tool for profiling patients according to the treatment pattern. The clinical application that motivated the study of this method concerns the mental health field. In fact, the care pathways of patients affected by severe mental disorders often do not correspond to the standards required by the guidelines in this field. In particular, we analyzed patients with schizophrenic disorders (i.e., schizophrenia, schizotypal or delusional disorders) using administrative data from 2015 to 2018 from Lombardy Region. This methodology considers the patient's therapeutic path as a conceptual unit, composed of a succession of different states, and we show how SSA can be used to describe longitudinal patient status. We define the states to be the weekly coverage of different treatments (psychiatric visits, psychosocial interventions, and anti-psychotic drugs), and we use the longest common subsequences (dis)similarity measure to compare and cluster the sequences. We obtained three different clusters with very different patterns of treatments. This kind of information, such as common patterns of care that allowed us to risk profile patients, can provide health policymakers an opportunity to plan optimum and individualized patient care by allocating appropriate resources, analyzing trends in the health status of a population, and finding the risk factors that can be leveraged to prevent the decline of mental health status at the population level.

Sections du résumé

BACKGROUND
Care pathways are increasingly being used to enhance the quality of care and optimize the use of resources for health care. Nevertheless, recommendations regarding the sequence of care are mostly based on consensus-based decisions as there is a lack of evidence on effective treatment sequences. In a real-world setting, classical statistical tools were insufficient to consider a phenomenon with such high variability adequately and have to be integrated with novel data mining techniques suitable for identifying patterns in complex data structures. Data-driven techniques can potentially support empirically identifying effective care sequences by extracting them from data collected routinely. The purpose of this study is to perform a state sequence analysis (SSA) to identify different patterns of treatment and to asses whether sequence analysis may be a useful tool for profiling patients according to the treatment pattern.
METHODS
The clinical application that motivated the study of this method concerns the mental health field. In fact, the care pathways of patients affected by severe mental disorders often do not correspond to the standards required by the guidelines in this field. In particular, we analyzed patients with schizophrenic disorders (i.e., schizophrenia, schizotypal or delusional disorders) using administrative data from 2015 to 2018 from Lombardy Region. This methodology considers the patient's therapeutic path as a conceptual unit, composed of a succession of different states, and we show how SSA can be used to describe longitudinal patient status.
RESULTS
We define the states to be the weekly coverage of different treatments (psychiatric visits, psychosocial interventions, and anti-psychotic drugs), and we use the longest common subsequences (dis)similarity measure to compare and cluster the sequences. We obtained three different clusters with very different patterns of treatments.
CONCLUSIONS
This kind of information, such as common patterns of care that allowed us to risk profile patients, can provide health policymakers an opportunity to plan optimum and individualized patient care by allocating appropriate resources, analyzing trends in the health status of a population, and finding the risk factors that can be leveraged to prevent the decline of mental health status at the population level.

Identifiants

pubmed: 37516839
doi: 10.1186/s12874-023-01993-7
pii: 10.1186/s12874-023-01993-7
pmc: PMC10386768
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

174

Informations de copyright

© 2023. The Author(s).

Références

Epidemiol Psychiatr Sci. 2022 Feb 14;31:e15
pubmed: 35156603
Int Clin Psychopharmacol. 2011 Jan;26(1):54-62
pubmed: 20881845
Behav Ther. 2020 Sep;51(5):675-687
pubmed: 32800297
Stat Methods Med Res. 2019 Jun;28(6):1651-1663
pubmed: 29717944
BMJ Open. 2017 Dec 26;7(12):e019503
pubmed: 29282274
Stat Methods Med Res. 2009 Feb;18(1):7-26
pubmed: 18562396
Int J Qual Health Care. 2003 Dec;15(6):523-30
pubmed: 14660535
Br J Psychiatry Suppl. 2007 Aug;50:s37-41
pubmed: 18019042
Hypertension. 2015 Mar;65(3):490-8
pubmed: 25624339
Value Health. 2009 Sep;12(6):989-95
pubmed: 19402852
Eur J Public Health. 2018 Apr 1;28(2):214-219
pubmed: 29040495
Epidemiol Psychiatr Sci. 2017 Aug;26(4):383-394
pubmed: 27780495
Ann Ist Super Sanita. 2009;45(1):5-16
pubmed: 19567972
Stat Methods Med Res. 2010 Jun;19(3):271-89
pubmed: 19608600
Biom J. 2021 Feb;63(2):305-322
pubmed: 32869340
Stat Methods Med Res. 2019 Jun;28(6):1731-1740
pubmed: 29742976
Clin Epidemiol. 2020 Oct 30;12:1205-1222
pubmed: 33154677
Drug Saf. 2019 Mar;42(3):347-363
pubmed: 30269245
Biom J. 2014 Sep;56(5):732-53
pubmed: 24421177
Pharmacoepidemiol Drug Saf. 2006 Aug;15(8):565-74; discussion 575-7
pubmed: 16514590
Soc Psychiatry Psychiatr Epidemiol. 2022 Mar;57(3):519-529
pubmed: 34132836
Rev Neurol (Paris). 2013 Jun-Jul;169(6-7):476-84
pubmed: 23623808
Rev Neurol (Paris). 2016 Apr-May;172(4-5):295-306
pubmed: 27038535
Pharmacoepidemiol Drug Saf. 2013 Nov;22(11):1146-53
pubmed: 24030723
Eur J Epidemiol. 2018 Jun;33(6):545-555
pubmed: 29605890
Int J Environ Res Public Health. 2021 Dec 20;18(24):
pubmed: 34949007
Int J Qual Health Care. 2016 Dec 01;28(6):728-733
pubmed: 27578632
BMJ Open. 2015 Jun 03;5(6):e007140
pubmed: 26041489
Ann Gen Psychiatry. 2013 Oct 23;12(1):32
pubmed: 24148707

Auteurs

Laura Savaré (L)

MOX - Department of Mathematics, Politecnico di Milano, Milan, Italy. laura.savare@polimi.it.
HDS, Health Data Science Center, Human Technopole, Milan, Italy. laura.savare@polimi.it.
National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy. laura.savare@polimi.it.

Francesca Ieva (F)

MOX - Department of Mathematics, Politecnico di Milano, Milan, Italy.
HDS, Health Data Science Center, Human Technopole, Milan, Italy.
National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.

Giovanni Corrao (G)

National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Unit of Biostatistics, Epidemiology and Public Health, Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.

Antonio Lora (A)

National Centre for Healthcare Research and Pharmacoepidemiology, University of Milano-Bicocca, Milan, Italy.
Department of Mental Health and Addiction Services, ASST Lecco, Lecco, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH